Mervyn Singer CS, Deutschman CW, Seymour, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10. https://doi.org/10.1001/jama.2016.0287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kristina E, Rudd SC, Johnson KM, Agesa, et al. Global, regional, and National sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet (London England). 2020;395:200–11. https://doi.org/10.1016/S0140-6736(19)32989-7.

Article  Google Scholar 

Weng L, Zeng Xy, Yin P, et al. Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med. 2018. https://doi.org/10.1007/s00134-018-5203-z. 44:.

Article  PubMed  Google Scholar 

Jianfeng Xie H, Wang Y, Kang, et al. The epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional survey. Crit Care Med. 2020;48:e209. https://doi.org/10.1097/CCM.0000000000004155.

Article  PubMed  Google Scholar 

Benjamin G, Chousterman FK, Swirski, Georg F, Weber. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517–28. https://doi.org/10.1007/s00281-017-0639-8.

Article  CAS  Google Scholar 

Lieuwe DJ, Bos, Lorraine B, Ware. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet (London England). 2022;400:1145–56. https://doi.org/10.1016/S0140-6736(22)01485-4.

Article  Google Scholar 

Giacomo Bellani JG, Laffey, Tài P, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. https://doi.org/10.1001/jama.2016.0291.

Article  CAS  PubMed  Google Scholar 

Chau-Chyun Sheu MN, Gong R, Zhai, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 2010;138:559–67. https://doi.org/10.1378/chest.09-2933.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhize Yuan Q, Wang Y, Tan, et al. Methylprednisolone alleviates lung injury in sepsis by regulating miR-151-5p/USP38 pathway. Int Immunopharmacol. 2024;138:112548. https://doi.org/10.1016/j.intimp.2024.112548.

Article  CAS  PubMed  Google Scholar 

Tu G-W, Shi Y, Zheng Y-J, et al. Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage. J Transl Med. 2017;15:181. https://doi.org/10.1186/s12967-017-1284-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mengting Qin Z Qiu. Changes in TNF-α, IL-6, IL-10 and VEGF in rats with ARDS and the effects of dexamethasone. Exp Ther Med. 2019;17:383–7. https://doi.org/10.3892/etm.2018.6926.

Article  CAS  PubMed  Google Scholar 

Bruno M, Tomazini IS, Maia AB, Cavalcanti, et al. Effect of dexamethasone on days alive and Ventilator-Free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307. https://doi.org/10.1001/jama.2020.17021.

Article  CAS  Google Scholar 

Jesús Villar C, Ferrando D, Martínez, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respiratory Med. 2020;8:267–76. https://doi.org/10.1016/S2213-2600(19)30417-5.

Article  Google Scholar 

Pierre-François Dequin F, Meziani J-P, Quenot, et al. Hydrocortisone in severe Community-Acquired pneumonia. N Engl J Med. 2023;388:1931–41. https://doi.org/10.1056/NEJMoa2215145.

Article  PubMed  Google Scholar 

Vito Fanelli Y, Morita P, Cappello, et al. Neuromuscular blocking agent cisatracurium attenuates lung injury by Inhibition of nicotinic acetylcholine Receptor-α1. Anesthesiology. 2016;124:132–40. https://doi.org/10.1097/ALN.0000000000000907.

Article  CAS  PubMed  Google Scholar 

Peter D, Sottile D, Albers MM, Moss. Neuromuscular Blockade is associated with the Attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome. Crit Care (London England). 2018;22:63. https://doi.org/10.1186/s13054-018-1974-4.

Article  Google Scholar 

Forel J-M, Roch A, Valérie Marin, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006;34:2749–57. https://doi.org/10.1097/01.CCM.0000239435.87433.0D.

Article  CAS  PubMed  Google Scholar 

Nur Canbolat B, Ozkul IH, Sever, et al. Vitamins C and E protect from sepsis-induced lung damage in rat and CT correlation. Bratisl Lek Listy. 2022;123:828–32. https://doi.org/10.4149/BLL_2022_132.

Article  PubMed  Google Scholar 

Bernard J, Fisher D, Kraskauskas EJ, Martin, et al. Mechanisms of Attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol. 2012;303:L20–32. https://doi.org/10.1152/ajplung.00300.2011.

Article  CAS  Google Scholar 

Bassem M, Mohammed BJ, Fisher D, Kraskauskas, et al. Vitamin C: a novel regulator of neutrophil extracellular trap formation. Nutrients. 2013;5:3131–51. https://doi.org/10.3390/nu5083131.

Article  CAS  Google Scholar 

Xian Qiao MG, Kashiouris ML’Heureux, et al. Biological effects of intravenous vitamin C on neutrophil extracellular traps and the endothelial glycocalyx in patients with Sepsis-Induced ARDS. Nutrients. 2022;14:4415. https://doi.org/10.3390/nu14204415.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alpha A, Fowler JD, Truwit R, Duncan Hite, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with Sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322:1261–70. https://doi.org/10.1001/jama.2019.11825.

Article  Google Scholar 

Gao D, Xu M, Wang G, et al. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging. 2021;13:7020–34. https://doi.org/10.18632/aging.202557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paul E, Marik V, Khangoora R, Rivera, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe Sepsis and septic shock: A retrospective Before-After study. Chest. 2017;151:1229–38. https://doi.org/10.1016/j.chest.2016.11.036.

Article  Google Scholar 

Fei Y, Huang X, Ning F, et al. NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and downstream pathways. Biomedecine Pharmacotherapie. 2024;175:116621. https://doi.org/10.1016/j.biopha.2024.116621.

Article  CAS  PubMed  Google Scholar 

Kodai Suzuki H, Okada G, Takemura, et al. Neutrophil elastase damages the pulmonary endothelial glycocalyx in Lipopolysaccharide-Induced experimental endotoxemia. Am J Pathol. 2019;189:1526–35. https://doi.org/10.1016/j.ajpath.2019.05.002.

Article  CAS  PubMed  Google Scholar 

Jiajia Ren G, Deng R, Li, et al. Possible Pharmacological targets and mechanisms of Sivelestat in protecting acute lung injury. Comput Biol Med. 2024;170:108080. https://doi.org/10.1016/j.compbiomed.2024.108080.

Article  CAS  PubMed  Google Scholar 

Yoshiaki Tsuboko S, Takeda S, Mii, et al. Clinical evaluation of Sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis. Drug Des Devel Ther. 2012;6:273–8. https://doi.org/10.2147/DDDT.S36436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao C, Hu W, Zhang Z, et al. Efficacy analysis and prognostic impact of Sivelestat sodium in coronavirus disease 2019-Related acute respiratory distress syndrome. Pharmaceuticals (Basel Switzerland). 2024;17:368. https://doi.org/10.3390/ph17030368.

Article  CAS  Google Scholar 

Lv H, Huang L, Yang X, et al. The clinical effectiveness of Sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy. J Cardiothorac Surg. 2024;19:399. https://doi.org/10.1186/s13019-024-02835-3.

Article  PubMed